VBI Vaccines Common Stock

VBI Vaccines (VBIV) currently reports a common stock of $460M as of March 2024. That compares with $440M in the prior-year period — up 2.9% year over year. Use the charts on this page to explore VBI Vaccines's common stock history and peer comparisons.

VBI Vaccines's common stock increased from $440M to $460M — a 2.9% year-over-year increase (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

VBI Vaccines reported $460M in common stock as of March 2024. That compares with $440M in the prior-year period — up 2.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $460M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for VBI Vaccines, and consider following VBIV for alerts when major investors trade the stock.

VBI Vaccines is classified in the Healthcare sector. On common stock, it currently shows $460M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VBIV with unrelated industries.